Massachusetts Selecta Biosciences' CEO to Retire at the End of 2018 Post author:Sam Post published:January 1, 2018 Post category:BioPharma Werner Cautreels, Ph.D., intends to retire effective December 31, 2018. Source: BioSpace You Might Also Like The Complicated Relationship Between Celgene and President Trump October 29, 2017 Cambridge's WuXi NextCODE Completes a Whopping $240 Million Funding Round September 6, 2017 Prof. Inventor Of Abx464, Abivax's Lead Drug Candidate For Inducing A Functional Cure For HIV, Awarded June 15, 2017
Prof. Inventor Of Abx464, Abivax's Lead Drug Candidate For Inducing A Functional Cure For HIV, Awarded June 15, 2017
